Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zabadinostat by IngenOx Therapeutics for Hepatocellular Carcinoma: Likelihood of Approval
Zabadinostat is under clinical development by IngenOx Therapeutics and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...